Keytruda (pembrolizumab)

pCPA File Number: 23321
Negotiation Status:
Concluded with an LOI
Indication(s):
For the treatment of adult patients with FIGO 2014 Stage III-IVA cervical cancer, in combination with chemoradiotherapy (CRT).
Sponsor/Manufacturer:
Merck Canada Inc.
CDA-AMC Project Number:
PC0411-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: